Records containing: Parkinson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-14Ambroxol as a Disease-modifying Treatment to Reduce the Risk of Cognitive Impairment in GBA-associated Parkinson's Disease. A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Trial
-
CLINICAL_TRIALS study record update · 2025-08-14Using Time Varying Non-Invasive Neuromodulation to Improve Neurovascular Status in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-13Comparison of Two Home-based Gait and Balance Trainings With Different Training Frequencies in Patients With Parkinson's Disease and Ataxia
-
CLINICAL_TRIALS study record update · 2025-08-13SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-12Clinical Study to Compare the Possible Safety and Efficacy of Pentoxifylline and Celecoxib in Patients With Parkinson's Disease Treated With Conventional Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-12Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
-
CLINICAL_TRIALS study record update · 2025-08-11A Randomized Phase 1b-2a Trial of the Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-08Development of New Multi-contrasts Approaches by Magnetic Resonance Imaging at 3 Tesla Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients.
-
CLINICAL_TRIALS study record update · 2025-08-08Autoimmune Features of Neurodegenerative Disorders
-
CLINICAL_TRIALS study record update · 2025-08-08Plasticity of Motor Systems in Early Stage Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-07The Novel Application of fNIRS-based Neurofeedback to Enhance Effects of Motor Imagery on Balance and Gait Performance in Individuals With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-07The Link Between the Training of Nursing Home Professionals and the Quality of Life of Residents With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-07Effects of Blood Pressure on Cognition and Cerebral Blood Flow in Parkinson Disease
-
CLINICAL_TRIALS study record update · 2025-08-07Novel Method for Diagnosis of Neurodegenerative Diseases Based on Saliva Biochemical Profiling
-
CLINICAL_TRIALS study record update · 2025-08-06An Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications
-
CLINICAL_TRIALS study record update · 2025-08-06Biomaterial Collection for Neurodegenerative Disease Research (ND Collection)
-
CLINICAL_TRIALS study record update · 2025-08-06Quantitation of Glymphatic Functioning in Sleep and Meditative States
-
CLINICAL_TRIALS study record update · 2025-08-06Phase 2b/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment of Dyskinesia in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
-
CLINICAL_TRIALS study record update · 2025-08-06Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna
-
CLINICAL_TRIALS study record update · 2025-08-05MARS-PD: Meridian Activation Remedy System for Parkinson's Disease - A Single-center, Rater-blinded, Parallel Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-08-05Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2025-08-03Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
-
CLINICAL_TRIALS study record update · 2025-08-01A Phase I, Open Label, Single Arm, Dose Escalation and Dose Expansion Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Human Induced Pluripotent Stem Cell Derived Dopaminergic Progenitor Cells (NCR201) Injection in the Treatment of Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-01EMPOWER PD - Feasibility of an Interdisciplinary Clinic for People With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-08-01Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease